| Name | Title | Contact Details |
|---|
Glossier is on a mission to give voice through beauty. We do this by building products, growing our community, and making decisions in inclusive, customer-devoted, curious, courageous, and discerning ways. We believe in the power of the individual and see beauty as an incredible conduit for connection. Glossier is sold in the United States, Canada, the United Kingdom, Ireland, Sweden, Denmark, and France. Glossier, Inc. was founded in 2014 by Founder & CEO Emily Weiss, has over 200 employees across three countries, and is building the future beauty company. Join us.
Viola was founded by Al Harrington, a former NBA player who was a first-round pick in the 1998 NBA draft. Viola`s mission is to consistently provide the community with ultra premium products.
101 Commerce is building a global, niche e-commerce platform serving multiple consumer categories using big data, artificial intelligence, blockchain, virtual reality and renewable energy.
Element is an innovative and research driven Canadian nutraceutical company specializing in the development of science-based products for the global consumer packaged goods market, with a portfolio focused specifically on men and women over the age of 50. Element`s lead product, Rejuvenate™, is a proprietary formulation that is clinically proven to assist in the rebuilding, restoration and rejuvenation of natural loss of muscle mass due to aging or other medical conditions. Element also offers JAKTRX™, an elite brand of performance supplements. Element was founded in 2015 and is located in Burlington, Ontario.
ChroMedX Corp. is a medical technology company focused on the development of novel, handheld medical devices for diagnostic testing at the patient`s bedside. HemoPalm, the Company`s lead product is the only handheld blood analysis system which combines Blood Gases & Electrolytes with full CO-oximetry. It has a single-use cartridge/handheld reader format, providing the simplest, most rapid and accurate testing process for use in management of critical care patients. Current blood gas systems require purchase of a second device to carry out CO-oximetry measurements. In addition, HemoPalm has the ability to draw capillary blood directly from pin-prick sites into the cartridge, as an alternative to the commonly required, risk-associated arterial blood draws. ChroMedX Corp. technologies are protected by the Company`s issued and pending patents, covering blood/plasma/serum collection, and processing and analysis.